Peptide Hormone Action in Diabetes

Peptide hormones, including glucagon-like peptide-1 (GLP-1) and amylin, are crucial for glucose regulation and appetite control. In diabetes, the secretion and action of these hormones are often impaired, contributing to dysregulated blood sugar levels and increased appetite. GLP-1 receptor agonists are a class of medications that mimic GLP-1's effects, enhancing insulin secretion and reducing postprandial glucose levels. Additionally, these hormones may promote weight loss by reducing appetite. Understanding the complex interactions between peptide hormones and glucose metabolism is vital for developing targeted therapies aimed at improving glycemic control and metabolic health in individuals with diabetes.